Clinical Trial: Invasives Aspergillosis in Acute Myeloid Leukemia

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: The Incidence of Invasive Aspergillosis in Acute Myeloid Leukemia

Brief Summary: Patients with acute myeloid leukemia (AML) are at risk to develop severe infections whose invasive aspergillosis (IA). These infections are leading to an important morbidity and mortality. Antifungal prophylaxis is recommended by posaconazole for AML patients during neutropenia induced by induction chemotherapy. Their application is not uniform.